AtriCure (ATRC) Total Non-Current Liabilities (2010 - 2026)
AtriCure's (ATRC) quarterly Total Non-Current Liabilities came in at $145.0 million in Q1 2026, up 6.76% year-on-year from $135.8 million in Q1 2025, and down 6.41% on a QoQ basis from $154.9 million in Q4 2025.
AtriCure (ATRC) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has 17 years of Total Non-Current Liabilities data on file, last reported at $145.0 million in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 6.76% year-over-year to $145.0 million in Q1 2026; TTM through Mar 2026 was $145.0 million, a 6.76% increase from a year earlier, with the FY2025 full-year figure at $154.9 million, up 5.27% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $145.0 million, down from $154.9 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for ATRC reached as high as $154.9 million in Q4 2025 and fell as low as $120.9 million in Q1 2022.
- Historically, Total Non-Current Liabilities has averaged $137.8 million across 5 years, with a median of $135.8 million in 2025.
- Across the five-year window, Total Non-Current Liabilities dropped 2.2% in 2022 and gained 14.95% in 2023, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $127.5 million in 2022, then gained by 14.95% to $146.5 million in 2023, then advanced by 0.42% to $147.1 million in 2024, then gained by 5.27% to $154.9 million in 2025, then fell by 6.41% to $145.0 million in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $145.0 million in Q1 2026, $154.9 million in Q4 2025, and $151.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | AtriCure | 1.60 Bn | 1.45 Bn | 109.31 Mn | 144.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144.98 Mn |
| Dec 31, 2025 | 154.90 Mn |
| Sep 30, 2025 | 151.57 Mn |
| Jun 30, 2025 | 143.19 Mn |
| Mar 31, 2025 | 135.79 Mn |
| Dec 31, 2024 | 147.15 Mn |
| Sep 30, 2024 | 148.84 Mn |
| Jun 30, 2024 | 134.00 Mn |
| Mar 31, 2024 | 134.07 Mn |
| Dec 31, 2023 | 146.53 Mn |
| Sep 30, 2023 | 136.21 Mn |
| Jun 30, 2023 | 130.53 Mn |
| Mar 31, 2023 | 127.02 Mn |
| Dec 31, 2022 | 127.47 Mn |
| Sep 30, 2022 | 130.38 Mn |
| Jun 30, 2022 | 129.46 Mn |
| Mar 31, 2022 | 120.93 Mn |
| Dec 31, 2021 | 130.34 Mn |
| Sep 30, 2021 | 122.22 Mn |
| Jun 30, 2021 | 123.48 Mn |